| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 08/15/2002 | US20020110857 Nucleotide sequences coding polypeptide for use in the treatment of fat defects |
| 08/15/2002 | US20020110855 Mammalian secreted proteins |
| 08/15/2002 | US20020110853 Polypeptide; for use in the treatment of tumors |
| 08/15/2002 | US20020110852 Peptide; for use in the treatment of pancreatic defects |
| 08/15/2002 | US20020110847 Method for measuring a state variable |
| 08/15/2002 | US20020110841 Regulation of cell growth by MUC1 |
| 08/15/2002 | US20020110836 PD-L2 molecules: novel PD-1 ligands and uses therefor |
| 08/15/2002 | US20020110832 Compositions and methods for the therapy and diagnosis of colon cancer |
| 08/15/2002 | US20020110830 Monitoring vascular endothelial growth factor activity in a sample; obtain sample, incubate with preferential genetically engineered cells, detecting expression of the reporter element, expression indicates growth factor activity |
| 08/15/2002 | US20020110829 Method for isolating nucleic acids from a liquid sample containing nucleic acids |
| 08/15/2002 | US20020110824 Screening for modulators of dermatitis; obtain tissue sample, incubate with modulator, monitor expression of preferential cytokine, presence of cytokine indicates dermatitis |
| 08/15/2002 | US20020110823 Screening human to determine proability of side effects to surgery; obtain tissue sample, extract nucleotide sequences, determine expression pattern of preferential genes |
| 08/15/2002 | US20020110822 Classification of preferential dermatitus; obtain skin sample, recover nucleotide sequences, monitor expression pattern of cytokine, classify dermatitis |
| 08/15/2002 | US20020110820 Classification of tumors; obtain tumor sample, monitor preferential gene expression pattern, compare to tumor control, classify tumor |
| 08/15/2002 | US20020110815 Nucleotide sequences which code polypeptide for use in the treatment of tumors |
| 08/15/2002 | US20020110814 Method and kit for the screening, the detection and/or the quantification of transcriptional factors |
| 08/15/2002 | US20020110812 Nucleic acid collection barrier method and apparatus |
| 08/15/2002 | US20020110805 Peptide for use in the treatment of glomerulonephritis, psoriasis, leukemia, antherosclerosis, autoimmune diseases, inflammatory, arthritic, asthmatic, and fibrotic disorders |
| 08/15/2002 | US20020110804 Secreted factors |
| 08/15/2002 | US20020110802 Expression vector for use as a tool for the generation of exogenous proteins |
| 08/15/2002 | US20020110691 Label bound via an amide bond and a linker to a residue of the molecule characterized in that the N atom of the amide bond and the label are linked together directly by a covalent bond; phosphoramidites or reactive supports |
| 08/15/2002 | US20020110566 Administering fusion protein comprising a heat shock protein (hsp) or an immunostimulatory fragment thereof, and protein of a human papilloma virus (HPV), or an antigenic fragment thereof, for therapy of wart |
| 08/15/2002 | US20020110565 Viral vectors having enhanced effectiveness with reduced virulence |
| 08/15/2002 | US20020110559 Confering an immune response to a tumor cell in a mammal by administering antibody which binds to aspartyl (asparaginyl) beta hydroxylase (HAAH) |
| 08/15/2002 | US20020110557 Cyanovirin conjugates and matrix-anchored cyanovirin and related compositions and methods of use |
| 08/15/2002 | US20020110550 Using esterase activity enzyme selected from pepper esterase and porcine esterase for protection of plant against phytopathogenic fuigi, protects plant against phytopathogenic fungi by inhibition of fungal appressorium formation |
| 08/15/2002 | US20020110548 Human GDP-mannose 4,6 dehydratase |
| 08/15/2002 | US20020110546 Implanting cells of an immortalized human neuro-derived fetal cell line into the host for therapy |
| 08/15/2002 | US20020110545 Adenovector pharmaceutical composition |
| 08/15/2002 | US20020110543 Viral delivery system for infectious transfer of large genomic DNA inserts |
| 08/15/2002 | US20020109607 Spread spectrum meter reading system utilizing low-speed/high-power frequency hopping |
| 08/15/2002 | US20020108930 Apparatus for removing native oxide layers from silicon wafers |
| 08/15/2002 | CA2447905A1 Hyperblebbing bacterial strains and use thereof for production of vaccines |
| 08/15/2002 | CA2440367A1 Aptamer-mediated regulation of gene expression |
| 08/15/2002 | CA2438376A1 Method and apparatus for the production of antigens and uses thereof |
| 08/15/2002 | CA2438018A1 Markers of unstable atherosclerotic plaques |
| 08/15/2002 | CA2437790A1 Replicative in vivo gene targeting |
| 08/15/2002 | CA2437727A1 Methods and compositions for modulating gluconeogenesis using pgc-1 |
| 08/15/2002 | CA2437717A1 G-protein coupled receptors |
| 08/15/2002 | CA2437714A1 Platlet glycoprotein ib alpha fusion polypeptides and methods of use thereof |
| 08/15/2002 | CA2437700A1 Regulation of cc chemokine receptor 3 (ccr3) expression |
| 08/15/2002 | CA2437665A1 Gap junction permeability assay |
| 08/15/2002 | CA2437648A1 Multipotent o-2a progenitors from the neurohypophysis |
| 08/15/2002 | CA2437606A1 Plant-derived molecules and genetic sequences encoding same and uses therefor |
| 08/15/2002 | CA2437596A1 Pro-apoptotic bacterial vaccines to enhance cellular immune responses |
| 08/15/2002 | CA2437577A1 Human sphingosine-1-phosphate phosphatase |
| 08/15/2002 | CA2437573A1 Methods for diagnosing and treating heart disease |
| 08/15/2002 | CA2437572A1 Method for the production of plant seed with modified fibre content and modified seed coat |
| 08/15/2002 | CA2437571A1 Receptors and membrane-associated proteins |
| 08/15/2002 | CA2437570A1 Methods for diagnosing and treating heart disease |
| 08/15/2002 | CA2437503A1 Hepatitis b virus treatment |
| 08/15/2002 | CA2437498A1 Methods and kits for identifying scavengers of reactive oxygen species (ros) |
| 08/15/2002 | CA2437497A1 Lipid-associated molecules |
| 08/15/2002 | CA2437484A1 Ragweed allergens |
| 08/15/2002 | CA2437461A1 Human phospholipase b-like polypeptide and uses thereof |
| 08/15/2002 | CA2437453A1 Conformationally abnormal forms of tau proteins and specific antibodies thereto |
| 08/15/2002 | CA2437434A1 Method for identifying compounds modulating reverse cholesterol transport |
| 08/15/2002 | CA2437423A1 Nucleic acid expressed in the hypothalamus or muscle tissue in obese animals |
| 08/15/2002 | CA2437383A1 Alteration of phenotype due to heterologous genes |
| 08/15/2002 | CA2437318A1 Nucleotide sequence mediating male fertility and method of using same |
| 08/15/2002 | CA2437309A1 Insertional mutagenesis technique |
| 08/15/2002 | CA2437276A1 Isolated human ras-like proteins, nucleic acid molecules encoding them, and uses thereof |
| 08/15/2002 | CA2437272A1 Modified erythropoietin (epo) with reduced immunogenicity |
| 08/15/2002 | CA2437270A1 Modified keratinocyte growth factor (kgf) with reduced immunogenicity |
| 08/15/2002 | CA2437267A1 Mixture of peptides originating from a nef protein and applications thereof |
| 08/15/2002 | CA2437265A1 Modified leptin with reduced immunogenicity |
| 08/15/2002 | CA2437263A1 Modified human brain-derived neutrophic factor (bdnf) with reduced immunogenicity |
| 08/15/2002 | CA2437214A1 Modified interleukin-1 receptor antagonist (il-1ra) with reduced immunogenicity |
| 08/15/2002 | CA2437189A1 Ap1 amine oxidase variants |
| 08/15/2002 | CA2437185A1 Timm8b-related protein |
| 08/15/2002 | CA2436986A1 Ter sites and ter binding proteins |
| 08/15/2002 | CA2436746A1 Charge tags and the separation of nucleic acid molecules |
| 08/15/2002 | CA2436743A1 Recombination method |
| 08/15/2002 | CA2436470A1 Intracellular signaling molecules |
| 08/15/2002 | CA2436448A1 Rare event detection system |
| 08/15/2002 | CA2436435A1 Vaccine composition |
| 08/15/2002 | CA2435608A1 Low affinity screening method |
| 08/15/2002 | CA2435292A1 Human hyperpolarization-activated cyclic nucleotide-gated cation channel hcn1 |
| 08/15/2002 | CA2434944A1 Secreted proteins |
| 08/15/2002 | CA2434881A1 Method for identifying functional nucleic acids |
| 08/15/2002 | CA2433439A1 Proteins and nucleic acids encoding same |
| 08/14/2002 | EP1231284A2 Method for serial analysis of gene expression |
| 08/14/2002 | EP1231283A2 Method of differentiating beer yeast |
| 08/14/2002 | EP1231280A1 METHOD OF DETECTING AND QUANTITATING MICROORGANISM HAVING SPECIFIC FUNCTION AND ITS GENE FROM NATURAL ENVIRONMENT, NOVEL 16SrRNA GENE DATA AND PROBES |
| 08/14/2002 | EP1231278A1 Cell-free method for preparing post-translational modified proteins |
| 08/14/2002 | EP1231277A2 Biocompatible implant for in vivo formation of a neo-organ |
| 08/14/2002 | EP1231276A1 Method for purifying proteins and/or biomolecule of protein complexes |
| 08/14/2002 | EP1231275A2 Peptide and protein fusions to thioredoxin and thioredoxin-like molecules |
| 08/14/2002 | EP1231274A2 Modified porteinase inhibitors |
| 08/14/2002 | EP1231273A1 Terpene synthase/cyclase and olefin synthase and uses thereof |
| 08/14/2002 | EP1231272A2 Procedure for obtaining bovine chymosin (rennin), curd |
| 08/14/2002 | EP1231271A2 DNA fragments of the GAG gene of Lav. |
| 08/14/2002 | EP1231270A1 Novel protein and dna thereof |
| 08/14/2002 | EP1231269A1 Methods and compositions for polypeptide engineering |
| 08/14/2002 | EP1231268A2 Polyclonal antibody libraries |
| 08/14/2002 | EP1231266A1 Arabidopsis-origin gdp-4-keto-6-deoxy-d-mannose-3,5-epimerase-4-reductase gene |
| 08/14/2002 | EP1231265A2 A receptor protein tyrosine kinase |
| 08/14/2002 | EP1231264A1 New protein |
| 08/14/2002 | EP1231263A1 Multipotent O-2A progenitors from the neurohypophysis |
| 08/14/2002 | EP1231262A1 Method of in vitro culture of lymphocytes and gene therapy compositions |